Cargando…
Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening
BACKGROUND: There is a need to develop blood-based bioassays for breast cancer (BC) screening. In this study, differential gene expression between BC samples and benign tumours was used to identify candidate biomarkers for blood-based screening. METHODS: We identified two proteins (Fibronectin 1 and...
Autores principales: | Ruiz-Garcia, E, Scott, V, Machavoine, C, Bidart, J M, Lacroix, L, Delaloge, S, Andre, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822945/ https://www.ncbi.nlm.nih.gov/pubmed/20068563 http://dx.doi.org/10.1038/sj.bjc.6605511 |
Ejemplares similares
-
CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Sato, Tomoo, et al.
Publicado: (2013) -
Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
por: Moledina, Dennis G., et al.
Publicado: (2023) -
CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022) -
Fibronectin Binding Modulates CXCL11 Activity and Facilitates Wound Healing
por: Tortelli, Federico, et al.
Publicado: (2013) -
Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions
por: Xia, Juan, et al.
Publicado: (2012)